Literature DB >> 4244848

Phenformin and stanozolol in blood fibrinolytic activity.

I S Menon, W J Cunliffe, D Weightman, H A Dewar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4244848      PMCID： PMC1699249          DOI： 10.1136/bmj.1.5693.428

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.

Authors:  G R Fearnley; R Chakrabarti; E D Hocking
Journal:  Lancet       Date:  1967-11-11       Impact factor: 79.321

2.  Role of the kidney in fibrinolytic activity of blood.

Authors:  I S Menon; H A Dewar; D J Newell
Journal:  Lancet       Date:  1968-04-13       Impact factor: 79.321

3.  Treatment of Behcet's syndrome with phenformin and ethyloestrenol.

Authors:  W J Cunliffe; I S Menon
Journal:  Lancet       Date:  1969-06-21       Impact factor: 79.321
  3 in total
  3 in total

1.  Antifibrin action of phenformin.

Authors:  R N Banerjee; V Kumar; S R Rao; A L Sahni; M Arya; J Bardhan
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

2.  Metformin and stanozolol in blood fibrinolytic activity.

Authors:  I S Menon
Journal:  Br Med J       Date:  1971-01-30

3.  The effect of the anabolic steroid stanozolol on tissue plasminogen activator activity and plasmin inhibition in the rat.

Authors:  A Smokovitis; B R Binder
Journal:  Experientia       Date:  1980-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.